How should regulatory decisions be made regarding endocrine disruption?

Currently there is no internationally agreed, scientific definition for endocrine disrupters (ED), nor clarity on the many proposed tests that may be used. Therefore it is important to realize that ED is a mechanism not an endpoint, and that chemicals demonstrating any ED potential should not be banned without risk assessment, to avoid regulatory decisions that are scientifically unsound and unworkable in practice. It is important that regulatory decisions to approve or to restrict the use of a chemical are made on the basis of sound science and not on subjectivity or political agendas.

It is essential to make the difference between endocrine disrupters and endocrine active substances.

Decisions must be based on the principles of risk assessment, considering both hazard and exposure.